Oncology Best Practices: Advances in Hematologic Malignancies
McCormick & Schmick’s
Bethesda, MD
July 14, 2009
| 6:00 pm | Registration, Dinner, and Networking |
| 6:25 pm | Welcome, Introductions, and Presession Survey Bruce D. Cheson |
| 6:30 pm | What’s New in the Management of Non-Hodgkin Lymphoma: Aggressive and T-Cell Lymphomas (including current and emerging treatment options for the optimal management of diffuse large B-cell, mantle cell, and T-cell lymphomas) Bruce D. Cheson |
| 6:55 pm | Question-and-Answer Session |
| 7:00 pm | Interactive Case Scenarios: Treatment of Patients With Diffuse Large B-Cell, Mantle Cell, and T-Cell Lymphomas |
| 7:30 pm | Update in the Treatment of Multiple Myeloma (including current therapeutic approaches to newly diagnosed myeloma, the use of novel agents to improve outcomes in transplantation-eligible and -ineligible patients, and treatment options for relapsed/refractory myeloma) Steven Treon |
| 7:55 pm | Question-and-Answer Session |
| 8:00 pm | Interactive Case Scenarios: Treatment of Patients With Newly Diagnosed Myeloma (Transplantation Eligible and Ineligible) and Relapsed/Refractory Myeloma |
| 8:30 pm | Closing Remarks and Adjourn Bruce D. Cheson |
An educational grant for this activity was provided by: